MedTest Announces Chemistry Instrument Acquisition Program for 2nd Quarter
Apr 5, 2016 - press releases
(Canton, Michigan) MedTest announces a commercial program for chemistry instrument acquisitions in the 2nd quarter (April – June, 2016). Customers have asked for assistance in acquiring new technology as they face decreasing reimbursement and aging instrumentation.
MedTest’s Got It
Need a robust floor-model chemistry analyzer with the latest technology at a bench-top analyzer price?
Need a robust bench-top analyzer at a POC device price?
Need 5 years of free service?
MedTest’s Got It. Call Us.
MedTest is the exclusive US distributor of the bench-top BS-200 and floor-model BS-480 Chemistry Analyzers. MedTest manufactures and distributes reagents, calibrators and quality control products for the general chemistry, special chemistry and drugs of abuse testing markets. These analyzers have best-in-class reliability, are easy to operate and require minimal operator time for maintenance procedures.
Hanjoon Ryu, CEO of MedTest, stated: “Today’s laboratory leaders are faced with aging equipment, reduced capital budgets, reduction in reimbursements and shortages in qualified laboratory staff. Our customers deserve an integrated provider who can help them meet these challenges by offering state-of-the-art instruments with expanding test menus at “never seen before” acquisition programs that will demonstrate economic advantages to the bottom line. MedTest is committed to providing superior price assurance and service assurance to our customers.”
About MedTest: MedTest is a diagnostics company that provides automated, fast, and cost effective blood and urine testing solutions for diabetes, cardiovascular disease, drugs of abuse, pain management and wellness testing. In June 2013, MedTest acquired Pointe Scientific, a US-based company that has been developing, manufacturing and distributing clinical diagnostic products including clinical chemistry reagents and instruments in the United States and internationally since 1981. In the fall of 2014, MedTest acquired Clinitox Diagnostix, a company that manufactures and supports drug confirmatory testing via Liquid Chromatography/Mass Spectrometry (LC/MS).
For additional information:
|Debbie Whitehair, MT(ASCP)SC|
|Vice President, Marketing|